| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $498.0M | +34.2% |
| Cost of Revenue | $95.8M | +22.7% |
| Gross Profit | $402.2M | +37.3% |
| R&D Expense | $135.5M | +12.6% |
| SG&A Expense | $156.8M | +34.0% |
| Operating Income | -$233.4M | -14.0% |
| Pre-tax Income | -$220.8M | -21.7% |
| Income Tax | $11.3M | +7.9% |
| Net Income | -$232.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $304.1M | -59.3% |
| Short-term Investments | $843.4M | +46.5% |
| Accounts Receivable | $70.5M | +36.2% |
| Current Assets | $1.28B | -10.2% |
| Total Assets | $1.38B | -6.9% |
| Current Liabilities | $271.7M | +21.6% |
| Total Liabilities | $328.4M | +34.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.5M | -122.0% |
| Capital Expenditures | $7.1M | +28.1% |
| Investing Cash Flow | -$284.8M | +32.2% |
| Financing Cash Flow | -$156.4M | -114.8% |
| Free Cash Flow | -$9.7M | -263.8% |
| -20.9% |
| EPS (Basic) | -$0.82 | +96.2% |
| EPS (Diluted) | -$0.82 | +96.2% |
| Stockholders' Equity |
| $1.05B |
| -15.0% |